|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-7-12
|
|
pubmed:abstractText |
B-type natriuretic peptide (BNP) is used to predict the clinical outcome of acute coronary syndromes, even in the absence of signs of cardiac failure. The triggers for BNP release have yet to be identified.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0001-5385
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
281-5
|
|
pubmed:meshHeading |
pubmed-meshheading:21744696-Aged,
pubmed-meshheading:21744696-Coronary Angiography,
pubmed-meshheading:21744696-Female,
pubmed-meshheading:21744696-Humans,
pubmed-meshheading:21744696-Male,
pubmed-meshheading:21744696-Middle Aged,
pubmed-meshheading:21744696-Myocardial Infarction,
pubmed-meshheading:21744696-Natriuretic Peptide, Brain,
pubmed-meshheading:21744696-Ventricular Dysfunction, Left
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
The determinants of B-type natriuretic peptide release in acute, non-ST-segment elevation myocardial infarction.
|
|
pubmed:affiliation |
Department of Cardiology, University Hospital Antwerp, Antwerp, Belgium. anne.vorlat@uza.be
|
|
pubmed:publicationType |
Journal Article
|
